Search - tctmd.com

Displaying 161 - 180 of 362

Sort: Relevancy | Date

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

News Daily News

More Women Than Men Develop HF or Die After STEMI

L.A. McKeown

December 01, 2020

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

News Conference News EAS 2020

Just One-Third of European Patients Get to LDL Cholesterol Goals

Michael O'Riordan

October 13, 2020

News Conference News EAS 2020

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

Michael O'Riordan

October 08, 2020

News Conference News ESC 2020

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Caitlin E. Cox

August 31, 2020

News Conference News ESC 2020

Trimetazidine Safe but Not Protective Long-term After PCI

Caitlin E. Cox

August 30, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

L.A. McKeown

August 04, 2020

News Daily News

Smoking Still Common, Tied to Higher Mortality in Young MI Patients

Yael L. Maxwell

July 09, 2020

News Daily News

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Yael L. Maxwell

July 07, 2020

A secondary analysis from ASPREE sets up two large RCTs testing statins in an elderly primary-prevention population.

News Daily News

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Michael O'Riordan

July 06, 2020

News Daily News

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Yael L. Maxwell

May 28, 2020

News Conference News ACC 2020

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Yael L. Maxwell

April 06, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

Hope for these hard-to-treat patients: more than half saw ≥ 50% decrease at 24 weeks, regardless of LDL receptor function.

News Conference News ACC 2020

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Yael L. Maxwell

April 01, 2020

News Daily News

Better Adherence to Guideline Advice Pays Off After Acute MI

Yael L. Maxwell

March 11, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

Shelley Wood

March 02, 2020

Advertisement

Inclisiran Approved in Europe for Lowering LDL Cholesterol

More Women Than Men Develop HF or Die After STEMI

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Just One-Third of European Patients Get to LDL Cholesterol Goals

Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention

LoDoCo2: Colchicine Protective in Large RCT of Chronic Coronary Disease

Trimetazidine Safe but Not Protective Long-term After PCI

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

Cholesterol Guidelines Fail Young MI Patients Who Might Have Benefited From Statins

Smoking Still Common, Tied to Higher Mortality in Young MI Patients

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly

Women, Elderly, Minorities Vastly Underrepresented in Clinical Trials Over Decades

Alirocumab Successfully Reduces LDL Cholesterol in Homozygous FH: ODYSSEY HoFH

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Evinacumab Cuts LDL Cholesterol in Homozygous FH

Better Adherence to Guideline Advice Pays Off After Acute MI

TCTMD’s Top 10 Most Popular Stories for February 2020

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content